ShareValue.ai

ShareValue scores for 300006.SHE: Valuation 44, Quality 29, Growth 47, Health 50.

300006.SHE
SZSE

Chongqing Lummy Pharmaceutical

CN¥4.73(+5.35%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 17%
Valuation
44
Fair Value
Price vs Value
Quality
29
Weak
Business Strength
Growth
47
Moderate
Revenue & Earnings
Health
50
Moderate
Financial Stability
Momentum
24
Bearish
Price Trend

Company Details

About

Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. The company was founded in 1999 and is headquartered in Chongqing, China.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026